D. P. Abhushan DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.75×0.75×0.75×0.74×0.75×
0.96×0.96×0.92×0.88×0.83×
7.6%7.2%4.9%4.0%3.7%
4.11×4.11×4.82×4.95×4.81×
1.81×1.81×2.07×2.25×2.25×
40.7%38.7%34.0%29.5%24.9%
40.9%40.9%35.1%29.5%28.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

DPABHUSHAN₹2,105.00

D. P. Abhushan Limited

· Consumer Goods
₹ CrorePeersGOLDIAMKDDLSHRINGARMSTBZMOTISONSSHANTIGOLDPNGSREVARGLMcap ₹4,805 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.750.740.750.750.75
Interest Burden (Pretax/EBIT) ×0.830.880.920.960.96
EBIT Margin %3.724.044.957.237.59
Asset Turnover ×4.814.954.824.114.11
Financial Leverage (Assets/Equity) ×2.252.252.071.811.81
ROE (5-step product, year-end total equity) %24.8829.4533.9938.6840.68
ROE (owners' profit / average owners' equity) %28.4029.4735.0640.8740.87
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.